Wnt signaling mediates pathological vascular growth in proliferative retinopathy - Wikidata - wikimedia - TriplyDB

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

http://www.wikidata.org/entity/Q42546329

about

Critical Endothelial Regulation by LRP5 during Retinal Vascular Development Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.Wnt signaling pathway in retinal vascularization Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice.LRP5 regulates development of lung microvessels and alveoli through the angiopoietin-Tie2 pathway The blood-brain barrier.Twist1 controls lung vascular permeability and endotoxin-induced pulmonary edema by altering Tie2 expression.Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching.Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway.Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy.Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina.Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization.The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration.Per2-Mediated Vascular Dysfunction Is Caused by the Upregulation of the Connective Tissue Growth Factor (CTGF).Using the past to inform the future: anti-VEGF therapy as a road map to develop novel therapies for diabetic retinopathy Lgr4 in ocular development and glaucoma TCF7L2 variation and proliferative diabetic retinopathy Novel targets against retinal angiogenesis in diabetic retinopathy.Glial influence on the blood brain barrier.Next-generation sequencing analysis of gene regulation in the rat model of retinopathy of prematurity.Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.Animal models of ocular angiogenesis: from development to pathologies.Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos.Functional Differences of Very-Low-Density Lipoprotein Receptor Splice Variants in Regulating Wnt Signaling.Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy.Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis.Targeting WNT Signaling for Multifaceted Glioblastoma Therapy.Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells.Wnt4/β-catenin signaling pathway modulates balloon-injured carotid artery restenosis via disheveled-1.Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species.Suppression of corneal neovascularization by curcumin via inhibition of Wnt/β-catenin pathway activation.miR-200b downregulates Kruppel Like Factor 2 (KLF2) during acute hypoxia in human endothelial cells.Molecular Regulation of Sprouting Angiogenesis.Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells.MicroRNA and Microvascular Complications of Diabetes.

P2860

Q27315201-D7B6E2D2-3109-4780-A5BA-A0B4CC85DEF5 Q33421226-D025F890-FDE1-4D1F-965C-DCD84DDCDCF1 Q33585501-F4E58FD6-0C0E-40DE-B597-F453D6B0F7DA Q33787188-3F5EC6A9-81F5-4900-8E9C-2E799C4E9C22 Q34137571-13936B44-F153-4179-B6BA-526A31F0F500 Q34358670-1FE680A6-2CE6-4502-B0D4-49FC41A0D205 Q34931170-2E35CFAC-8483-4DD6-8405-F85451CAF954 Q34984424-E4622090-4B7E-432E-B4BE-5DFFD25A9B64 Q34995007-CF108DAC-449D-4EC3-A1B5-FECB8FA820FF Q34996091-CC4B947A-625E-4255-BC52-6D519D8A7C89 Q35006465-AC9FC4BF-F59B-4813-8445-201FB2886ED3 Q35085010-58ADFD12-6D41-4152-A165-053F1EC4DD5A Q35224472-915BA1EF-D3B2-444E-AF1F-1A396F7D67E4 Q35597138-2456CC6E-519B-40B9-9C09-257D7FDA86EE Q35717941-44E3C19B-A5F4-4175-AC65-2559A5C7E415 Q35776933-BFC919DD-A5CC-47A0-9BED-44645EBEDDF7 Q35807878-35E549AA-6339-45D2-8354-D99D4A773786 Q36102528-41872EA8-F3CF-4A9B-9AD9-FB5E6FCA22C9 Q36143132-63443D05-B6C4-4C03-9FD7-5D85888B00F3 Q36867626-93E3CD3D-23F3-42DB-A9B7-E6A18D0CC7C8 Q36942765-CA409EB0-B928-452E-87D9-11E922B3DB5B Q37015022-D5F8AB87-183F-44EE-A7B7-81A7E28535DE Q38013679-613E8FA3-F962-4AE9-8C94-B7D37A2C4C07 Q38152380-9CE94C5E-59F9-44E4-AC73-5EB6AB3AD793 Q38488946-335E59E9-3491-42E9-BEBF-01A47B57532A Q38913007-F96CAACE-60D9-4269-B293-CF6BB03F7737 Q39455385-DC82718C-C6F5-45DB-B639-E82BB72D9790 Q40218186-4D4EF778-40C3-48FC-90E5-3C8E6BAE8F05 Q41193795-670CD565-3238-4D5E-980F-F849B2C352AF Q41630160-88889A75-C961-48F9-AB23-C1464362E5B9 Q41701186-D170DC44-69B8-4B7D-ADD2-5B3AE2EFCCA0 Q42683185-8B4B84B4-19A0-44D8-BA1A-E38F94C0C3BD Q42872661-E22FE5E9-DC65-47CC-8617-D65C5B08998C Q43127112-7FB3F328-73A3-4FA5-94D3-ED1D83C62586 Q46849161-82033231-377D-4DC6-99DD-2E42D5BB0B83 Q47272524-37C6382E-3A4A-41CE-BD2D-2BA73BCF3177 Q50084870-61CC98FA-343F-46DB-8D90-0D31D203175C Q50423780-820977C7-06F4-485D-AE5A-46C1E95B2042 Q50431262-AECC6BF1-6FC6-4D95-B3A3-A85061B26A82 Q55262853-E5C4A70A-E21A-4CF9-8145-7617FA2A2A10

P2860

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

http://www.wikidata.org/entity/Q42546329

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@en

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@nl

type

label

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@en

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@nl

prefLabel

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@en

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@nl

P1433

Q42546329-4105C3AB-C394-4B73-8DF5-95543D9BF226

P1476

Q42546329-C419039A-A256-4D50-AA29-2FF5C7EA472C

P2093

Q42546329-13BAEC71-D725-4BD3-B096-53F807733F6C

Q42546329-1A7AA134-5A79-472A-BF8D-4B6A6DB0D386

Q42546329-2B00AA5D-A6F4-41DA-AF2B-19400315899C

Q42546329-2FBD6952-CEC0-49FD-8AA1-290673069C04

Q42546329-3B94E860-88EA-43CB-BF7E-2C914776CAC6

Q42546329-46389A71-1821-458E-9254-EBB5F8D81AA5

Q42546329-64665EE9-E59F-44AA-86C6-9A74A2DC4D39

Q42546329-6D163B74-9218-4FA1-AFC4-0286F11C423E

Q42546329-75980C5A-C149-46E9-96F8-A9EFF9DCAE79

Q42546329-7B5DD142-D2E4-4945-8F70-537EC4C69C5B

P2860

Q42546329-02E8CB1B-C710-4D9F-8EFD-9467FD64CBE0

Q42546329-03D3B7E5-9729-427E-9B67-8C25E06136C9

Q42546329-03DD0761-8974-4203-993C-08955156D4F4

Q42546329-042A1D25-888D-40C4-8DD0-F264FDA34620

Q42546329-05B7F148-5A85-4D6E-83BF-FD7543D9D465

Q42546329-05C5355B-8ECC-4978-AF67-4295490BD43F

Q42546329-11510883-6F43-45E6-95AD-99D0D5AEFF6B

Q42546329-127ACD15-FF07-4B5F-802F-535E4872D714

Q42546329-12F9BC10-EB08-430B-BC10-6724AA6B35CD

Q42546329-146A9200-6E61-4748-BB75-B014CC86DB24

P304

Q42546329-05DAB229-BB39-465E-A407-4486AF7045FF

P31

Q42546329-B976E755-FCC0-4238-9B22-824D10C1673D

P356

Q42546329-FB260C65-83CE-4FBC-814B-A6D839D5B282

P407

Q42546329-B2362B63-9AD0-4241-92E2-7B20A64B54F5

P433

Q42546329-EE6652DE-DC0E-4EA7-B3BC-21CD24EA4C0F

P478

Q42546329-B9F913F6-24B9-4E62-B86F-35DFC2F63D46

P50

Q42546329-364B875A-75EC-4917-9503-0BC061C406BB

P577

Q42546329-8961F1C7-BDEB-499B-88D4-DCFC98E2DF80

P698

Q42546329-011F3E55-F36A-4924-B6DC-B86BCF607BEC

P932

Q42546329-CFE987E1-14EA-4AAF-A9AF-8E3698D6FD22

P356

CIRCULATIONAHA.111.040337

P1433

P1476

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

@en

P2093

Aimee M Juan

http://www.w3.org/2001/XMLSchema#string

Andreas Stahl

http://www.w3.org/2001/XMLSchema#string

Christopher M Aderman

http://www.w3.org/2001/XMLSchema#string

Colman J Hatton

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Jing Hua

http://www.w3.org/2001/XMLSchema#string

Karen I Guerin

http://www.w3.org/2001/XMLSchema#string

Keirnan L Willett

http://www.w3.org/2001/XMLSchema#string

Lois E H Smith

http://www.w3.org/2001/XMLSchema#string

Matthew Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function

Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5.

Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis

Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair

A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy

The prototype endothelial marker PAL-E is a leukocyte trafficking molecule

TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling

P304

1871-1881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.111.040337

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21969016

http://www.w3.org/2001/XMLSchema#string

P932

3326389

http://www.w3.org/2001/XMLSchema#string